Epothilone B [152044-54-7]

Référence HY-17029-5mg

Conditionnement : 5mg

Marque : MedChemExpress

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

Description

Epothilone B is a microtubule stabilizer (MSA) with a Ki of 0.71μM, and is a MSA with blood-brain barrier permeability. Epothilone B acts by binding to the αβ-tubulin heterodimer subunit which causes decreasing of αβ-tubulin dissociation[1][2][3][4].

IC50 & Target

EC0.01: 1.8 μM (Microtubule/Tubulin)[1]

Cellular Effect
Cell Line Type Value Description References
1A9 IC50
0.06 nM
Compound: 11
Cytotoxicity against human 1A9 cells
Cytotoxicity against human 1A9 cells
[PMID: 28850227]
1A9 IC50
0.13 nM
Compound: 175 (Epothilone B)
Inhibitory concentration against ovarian carcinoma 1A9 cell growth
Inhibitory concentration against ovarian carcinoma 1A9 cell growth
[PMID: 16134928]
1A9/ptx-10 IC50
1 nM
Compound: 175 (Epothilone B)
Inhibitory concentration against beta-tubulin mutant 1A9PTX10 cell growth
Inhibitory concentration against beta-tubulin mutant 1A9PTX10 cell growth
[PMID: 16134928]
1A9/ptx-22 IC50
0.31 nM
Compound: 175 (Epothilone B)
Inhibitory concentration against beta-tubulin mutant 1A9PTX22 cell line
Inhibitory concentration against beta-tubulin mutant 1A9PTX22 cell line
[PMID: 16134928]
A2780 EC50
4 nM
Compound: Epothilone B
Antiproliferative activity against D4-9-31 resistance human A2780 cells incubated for 72 hrs by ATPlite reagent based assay
Antiproliferative activity against D4-9-31 resistance human A2780 cells incubated for 72 hrs by ATPlite reagent based assay
[PMID: 31047749]
A2780 EC50
5.2 nM
Compound: Epothilone B
Antiproliferative activity against human A2780 cells incubated for 72 hrs by ATPlite reagent based assay
Antiproliferative activity against human A2780 cells incubated for 72 hrs by ATPlite reagent based assay
[PMID: 31047749]
A-431 IC50
5.1 × 10-5μM
Compound: Epothilone B
Antiproliferative activity against human A-431 cells assessed as cell growth inhibition
Antiproliferative activity against human A-431 cells assessed as cell growth inhibition
[PMID: 37931226]
A-431 IC50
5.1 x 10-5μM
Compound: Epothilone B
Antiproliferative activity against human A-431 cells assessed as cell growth inhibition
Antiproliferative activity against human A-431 cells assessed as cell growth inhibition
[PMID: 37931226]
A-431 IC50
6.7 × 10-5M
Compound: Epothilone B
Cytotoxicity against human A-431 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against human A-431 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
A-431 IC50
6.7 x 10-5M
Compound: Epothilone B
Cytotoxicity against human A-431 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against human A-431 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
A-431 IC50
67 μM
Compound: Epothilone B
Cytotoxicity against human A-431 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against human A-431 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
A-431 IC50
7.3 × 10-5μM
Compound: Epothilone B
Cytotoxicity against human A431 cells assessed as reduction in cell viability after 5 days by MTT assay
Cytotoxicity against human A431 cells assessed as reduction in cell viability after 5 days by MTT assay
[PMID: 28398049]
A-431 IC50
7.3 x 10-5μM
Compound: Epothilone B
Cytotoxicity against human A431 cells assessed as reduction in cell viability after 5 days by MTT assay
Cytotoxicity against human A431 cells assessed as reduction in cell viability after 5 days by MTT assay
[PMID: 28398049]
A-431 IC50
7.9 × 10-5μM
Compound: Epothilone B
Cytotoxicity against human A431 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
Cytotoxicity against human A431 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
[PMID: 31599583]
A-431 IC50
7.9 x 10-5μM
Compound: Epothilone B
Cytotoxicity against human A431 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
Cytotoxicity against human A431 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
[PMID: 31599583]
A549 GI50
0.7 nM
Compound: Epothilone B
Growth inhibition of human A549 cells after 4 days by SRB assay
Growth inhibition of human A549 cells after 4 days by SRB assay
[PMID: 28740601]
A549 IC50
1.5 × 10-4μM
Compound: Epothilone B
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 5 days by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 5 days by MTT assay
[PMID: 28398049]
A549 IC50
1.5 x 10-4μM
Compound: Epothilone B
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 5 days by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 5 days by MTT assay
[PMID: 28398049]
A549 IC50
4 nM
Compound: Epothilone B
Cytotoxicity against human A549 cells measured after 5 days by MTT assay
Cytotoxicity against human A549 cells measured after 5 days by MTT assay
[PMID: 31021629]
A549 IC50
4 × 10-3μM
Compound: Epothilone B
Cytotoxicity against human A549 cells measured after 5 days by MTT assay
Cytotoxicity against human A549 cells measured after 5 days by MTT assay
[PMID: 31021629]
A549 IC50
4 x 10-3μM
Compound: Epothilone B
Cytotoxicity against human A549 cells measured after 5 days by MTT assay
Cytotoxicity against human A549 cells measured after 5 days by MTT assay
[PMID: 31021629]
A549 IC50
5.3 × 10-5μM
Compound: Epothilone B
Antiproliferative activity against human A549 cells assessed as cell growth inhibition
Antiproliferative activity against human A549 cells assessed as cell growth inhibition
[PMID: 37931226]
A549 IC50
5.3 x 10-5μM
Compound: Epothilone B
Antiproliferative activity against human A549 cells assessed as cell growth inhibition
Antiproliferative activity against human A549 cells assessed as cell growth inhibition
[PMID: 37931226]
A549 IC50
6.9 × 10-5μM
Compound: Epothilone B
Cytotoxicity against human A549 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
[PMID: 31599583]
A549 IC50
6.9 x 10-5μM
Compound: Epothilone B
Cytotoxicity against human A549 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
[PMID: 31599583]
A549 IC50
8.8 × 10-5M
Compound: Epothilone B
Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
A549 IC50
8.8 x 10-5M
Compound: Epothilone B
Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
A549 IC50
88 μM
Compound: Epothilone B
Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
Bel-7402 IC50
0.9 nM
Compound: Epothilone B
Antiproliferative activity against human Bel7402 after 72 hrs by CellTiter Glo assay
Antiproliferative activity against human Bel7402 after 72 hrs by CellTiter Glo assay
[PMID: 22320354]
HCC1937 IC50
>10 μM
Compound: Epothilone B
Antiproliferative activity against exponentially growing adherent human HCC1937 cells assessed as inhibition of cell proliferation after 72 hrs by luminescence detection based ATPlite assay
Antiproliferative activity against exponentially growing adherent human HCC1937 cells assessed as inhibition of cell proliferation after 72 hrs by luminescence detection based ATPlite assay
[PMID: 25872984]
HCT-116 IC50
0.8 nM
Compound: 2; EPO B
Antiproliferative activity against human HCT116 cells assessed as inhibition of cell proliferation
Antiproliferative activity against human HCT116 cells assessed as inhibition of cell proliferation
[PMID: 30149324]
HeLa IC50
3 nM
Compound: 2; EPO B
Cytotoxicity against human HeLa cells
Cytotoxicity against human HeLa cells
[PMID: 30149324]
Hep 3B2 IC50
>100 nM
Compound: Epothilone B
Antiproliferative activity against human Hep3B after 72 hrs by CellTiter Glo assay
Antiproliferative activity against human Hep3B after 72 hrs by CellTiter Glo assay
[PMID: 22320354]
HepG2 EC50
0.01 μM
Compound: Epothilone B
Activation of rat PXR expressed in human HepG2 cells after 24 hrs by luciferase reporter gene based luminescent analysis
Activation of rat PXR expressed in human HepG2 cells after 24 hrs by luciferase reporter gene based luminescent analysis
[PMID: 20966043]
HepG2 EC50
12.6 μM
Compound: Epothilone B
Activation of human PXR expressed in human HepG2 (DPX-2) cells after 24 hrs by luciferase reporter gene based luminescent analysis
Activation of human PXR expressed in human HepG2 (DPX-2) cells after 24 hrs by luciferase reporter gene based luminescent analysis
[PMID: 20966043]
HepG2 IC50
44.7 nM
Compound: Epothilone B
Antiproliferative activity against human HepG2 after 72 hrs by CellTiter Glo assay
Antiproliferative activity against human HepG2 after 72 hrs by CellTiter Glo assay
[PMID: 22320354]
Hs-578T IC50
3 nM
Compound: 2; EPO B
Cytotoxicity against human Hs 578T cells
Cytotoxicity against human Hs 578T cells
[PMID: 30149324]
Huh-7 CC50
>6.25 μM
Compound: GNF-Pf-193
NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)
NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)
[PMID: 18579783]
Huh-7 IC50
4.5 nM
Compound: Epothilone B
Antiproliferative activity against human HuH7 after 72 hrs by CellTiter Glo assay
Antiproliferative activity against human HuH7 after 72 hrs by CellTiter Glo assay
[PMID: 22320354]
HUVEC IC50
0.00055 μM
Compound: Epothilone B
Cytotoxicity against HUVEC after 5 days by MTT assay
Cytotoxicity against HUVEC after 5 days by MTT assay
[PMID: 27231731]
HUVEC IC50
0.55 nM
Compound: Epothilone B
Cytotoxicity against HUVEC after 5 days by MTT assay
Cytotoxicity against HUVEC after 5 days by MTT assay
[PMID: 27231731]
KB IC50
0.18 nM
Compound: Epothilone B
Concentration required to inhibit the growth of paclitaxel-resistant human epidermoid carcinoma cells KB-8511 by 50 percent (72 hr exposure)
Concentration required to inhibit the growth of paclitaxel-resistant human epidermoid carcinoma cells KB-8511 by 50 percent (72 hr exposure)
[PMID: 11133086]
KB 3-1 IC50
0.00022 μM
Compound: Epothilone B
Cytotoxicity against human KB 3.1 cells after 5 days by MTT assay
Cytotoxicity against human KB 3.1 cells after 5 days by MTT assay
[PMID: 27231731]
KB 3-1 IC50
0.19 nM
Compound: Epothilone B
Concentration required to inhibit the growth of paclitaxel-sensitive human epidermoid carcinoma cells KB-31 by 50 percent (72 hr exposure)
Concentration required to inhibit the growth of paclitaxel-sensitive human epidermoid carcinoma cells KB-31 by 50 percent (72 hr exposure)
[PMID: 11133086]
KB 3-1 IC50
0.22 μM
Compound: Epothilon B
Cytotoxicity against human KB 3.1 cells assessed as inhibition of cell growth after 5 days by MTT assay
Cytotoxicity against human KB 3.1 cells assessed as inhibition of cell growth after 5 days by MTT assay
[PMID: 29489350]
KB 3-1 IC50
0.22 nM
Compound: Epothilone B
Cytotoxicity against human KB 3.1 cells after 5 days by MTT assay
Cytotoxicity against human KB 3.1 cells after 5 days by MTT assay
[PMID: 27231731]
KB 3-1 IC50
3 nM
Compound: 2; EPO B
Cytotoxicity against human KB3-1 cells
Cytotoxicity against human KB3-1 cells
[PMID: 30149324]
KB 3-1 IC50
3.4 × 10-5μM
Compound: Epothilone B
Antiproliferative activity against human KB-3-1 cells assessed as cell growth inhibition
Antiproliferative activity against human KB-3-1 cells assessed as cell growth inhibition
[PMID: 37931226]
KB 3-1 IC50
3.4 x 10-5μM
Compound: Epothilone B
Antiproliferative activity against human KB-3-1 cells assessed as cell growth inhibition
Antiproliferative activity against human KB-3-1 cells assessed as cell growth inhibition
[PMID: 37931226]
KB 3-1 IC50
5.3 × 10-5μM
Compound: Epothilone B
Cytotoxicity against human KB3-1 cells measured after 5 days by MTT assay
Cytotoxicity against human KB3-1 cells measured after 5 days by MTT assay
[PMID: 31021629]
KB 3-1 IC50
5.3 x 10-5μM
Compound: Epothilone B
Cytotoxicity against human KB3-1 cells measured after 5 days by MTT assay
Cytotoxicity against human KB3-1 cells measured after 5 days by MTT assay
[PMID: 31021629]
KB 3-1 IC50
6.1 × 10-5μM
Compound: Epothilone B
Cytotoxicity against human KB3-1 cells assessed as reduction in cell viability after 5 days by MTT assay
Cytotoxicity against human KB3-1 cells assessed as reduction in cell viability after 5 days by MTT assay
[PMID: 28398049]
KB 3-1 IC50
6.1 x 10-5μM
Compound: Epothilone B
Cytotoxicity against human KB3-1 cells assessed as reduction in cell viability after 5 days by MTT assay
Cytotoxicity against human KB3-1 cells assessed as reduction in cell viability after 5 days by MTT assay
[PMID: 28398049]
KB 3-1 IC50
6.5 × 10-5μM
Compound: Epothilone B
Cytotoxicity in human KB 3.1 cells
Cytotoxicity in human KB 3.1 cells
[PMID: 31001977]
KB 3-1 IC50
6.5 x 10-5μM
Compound: Epothilone B
Cytotoxicity in human KB 3.1 cells
Cytotoxicity in human KB 3.1 cells
[PMID: 31001977]
KB 3-1 IC50
6.9 × 10-5M
Compound: Epothilone B
Cytotoxicity against human KB 3-1 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against human KB 3-1 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
KB 3-1 IC50
6.9 x 10-5M
Compound: Epothilone B
Cytotoxicity against human KB 3-1 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against human KB 3-1 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
KB 3-1 IC50
69 μM
Compound: Epothilone B
Cytotoxicity against human KB 3-1 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against human KB 3-1 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
KB 3-1 IC50
8.6 x 10-6μg/mL
Compound: Epothilone B
Cytotoxicity against human KB-3-1 cells assessed as inhibition of cell growth incubated for 5 days by MTT assay
Cytotoxicity against human KB-3-1 cells assessed as inhibition of cell growth incubated for 5 days by MTT assay
[PMID: 39141525]
KB 3-1 IC50
8.9 × 10-5μM
Compound: Epothilon B
Cytotoxicity against human KB3.1 cells assessed as reduction in cell viability by MTT assay
Cytotoxicity against human KB3.1 cells assessed as reduction in cell viability by MTT assay
[PMID: 32786884]
KB 3-1 IC50
8.9 × 10-5μM
Compound: Epothilone B
Cytotoxicity against human KB3-1 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
Cytotoxicity against human KB3-1 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
[PMID: 31599583]
KB 3-1 IC50
8.9 x 10-5μM
Compound: Epothilon B
Cytotoxicity against human KB3.1 cells assessed as reduction in cell viability by MTT assay
Cytotoxicity against human KB3.1 cells assessed as reduction in cell viability by MTT assay
[PMID: 32786884]
KB 3-1 IC50
8.9 x 10-5μM
Compound: Epothilone B
Cytotoxicity against human KB3-1 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
Cytotoxicity against human KB3-1 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
[PMID: 31599583]
KB-V1 IC50
3 nM
Compound: 2; EPO B
Cytotoxicity against human KBV1 cells
Cytotoxicity against human KBV1 cells
[PMID: 30149324]
L929 IC50
0.00275 μM
Compound: Epothilone B
Cytotoxicity in mouse L929 cells
Cytotoxicity in mouse L929 cells
[PMID: 31001977]
L929 IC50
1 ng/mL
Compound: 2
Cytotoxicity against mouse L929 cells
Cytotoxicity against mouse L929 cells
[PMID: 11473410]
L929 IC50
1.4 mM
Compound: Epothilone B
Cytotoxicity against mouse L929 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against mouse L929 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
L929 IC50
1.4 nM
Compound: Epothilone B
Cytotoxicity against mouse L929 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
Cytotoxicity against mouse L929 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
[PMID: 31599583]
L929 IC50
1.4 μM
Compound: Epothilon B
Cytotoxicity against mouse L929 cells assessed as inhibition of cell growth after 5 days by MTT assay
Cytotoxicity against mouse L929 cells assessed as inhibition of cell growth after 5 days by MTT assay
[PMID: 29489350]
L929 IC50
1.4 × 10-3M
Compound: Epothilone B
Cytotoxicity against mouse L929 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against mouse L929 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
L929 IC50
1.4 × 10-3μM
Compound: Epothilone B
Cytotoxicity against mouse L929 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
Cytotoxicity against mouse L929 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
[PMID: 31599583]
L929 IC50
1.4 x 10-3M
Compound: Epothilone B
Cytotoxicity against mouse L929 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against mouse L929 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
L929 IC50
1.4 x 10-3μM
Compound: Epothilone B
Cytotoxicity against mouse L929 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
Cytotoxicity against mouse L929 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
[PMID: 31599583]
L929 IC50
1.7 nM
Compound: Epothilone B
Cytotoxicity against mouse L929 cells assessed as reduction in cell viability after 5 days by MTT assay
Cytotoxicity against mouse L929 cells assessed as reduction in cell viability after 5 days by MTT assay
[PMID: 28398049]
L929 IC50
1.7 × 10-3μM
Compound: Epothilone B
Cytotoxicity against mouse L929 cells assessed as reduction in cell viability after 5 days by MTT assay
Cytotoxicity against mouse L929 cells assessed as reduction in cell viability after 5 days by MTT assay
[PMID: 28398049]
L929 IC50
1.7 x 10-3μM
Compound: Epothilone B
Cytotoxicity against mouse L929 cells assessed as reduction in cell viability after 5 days by MTT assay
Cytotoxicity against mouse L929 cells assessed as reduction in cell viability after 5 days by MTT assay
[PMID: 28398049]
L929 IC50
2.6 nM
Compound: Epothilon B
Cytotoxicity against mouse L929 cells assessed as reduction in cell viability by MTT assay
Cytotoxicity against mouse L929 cells assessed as reduction in cell viability by MTT assay
[PMID: 32786884]
L929 IC50
2.6 × 10-3μM
Compound: Epothilon B
Cytotoxicity against mouse L929 cells assessed as reduction in cell viability by MTT assay
Cytotoxicity against mouse L929 cells assessed as reduction in cell viability by MTT assay
[PMID: 32786884]
L929 IC50
2.6 x 10-3μM
Compound: Epothilon B
Cytotoxicity against mouse L929 cells assessed as reduction in cell viability by MTT assay
Cytotoxicity against mouse L929 cells assessed as reduction in cell viability by MTT assay
[PMID: 32786884]
L929 IC50
4.3 × 10-4μM
Compound: Epothilone B
Antiproliferative activity against mouse L929 cells assessed as cell growth inhibition
Antiproliferative activity against mouse L929 cells assessed as cell growth inhibition
[PMID: 37931226]
L929 IC50
4.3 x 10-4μM
Compound: Epothilone B
Antiproliferative activity against mouse L929 cells assessed as cell growth inhibition
Antiproliferative activity against mouse L929 cells assessed as cell growth inhibition
[PMID: 37931226]
L929 IC50
7.5 × 10-4μM
Compound: Epothilone B
Cytotoxicity against mouse L929 cells measured after 5 days by MTT assay
Cytotoxicity against mouse L929 cells measured after 5 days by MTT assay
[PMID: 31021629]
L929 IC50
7.5 x 10-4μM
Compound: Epothilone B
Cytotoxicity against mouse L929 cells measured after 5 days by MTT assay
Cytotoxicity against mouse L929 cells measured after 5 days by MTT assay
[PMID: 31021629]
L929 IC50
8.6 x 10-5μg/mL
Compound: Epothilone B
Cytotoxicity against mouse L929 cells assessed as inhibition of cell growth incubated for 5 days by MTT assay
Cytotoxicity against mouse L929 cells assessed as inhibition of cell growth incubated for 5 days by MTT assay
[PMID: 39141525]
MCF7 ED50
0.0015 μM
Compound: 1b
Cytotoxicity against human MCF7 cells by phototoxicity labeling study
Cytotoxicity against human MCF7 cells by phototoxicity labeling study
[PMID: 19428248]
MCF7 IC50
1.5 × 10-4μM
Compound: Epothilone B
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 5 days by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 5 days by MTT assay
[PMID: 28398049]
MCF7 IC50
1.5 x 10-4μM
Compound: Epothilone B
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 5 days by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 5 days by MTT assay
[PMID: 28398049]
MCF7 IC50
2.4 × 10-4μM
Compound: Epothilone B
Cytotoxicity against human MCF7 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
[PMID: 31599583]
MCF7 IC50
2.4 x 10-4μM
Compound: Epothilone B
Cytotoxicity against human MCF7 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
[PMID: 31599583]
MCF7 IC50
3 × 10-5μM
Compound: Epothilone B
Antiproliferative activity against human MCF7 cells assessed as cell growth inhibition
Antiproliferative activity against human MCF7 cells assessed as cell growth inhibition
[PMID: 37931226]
MCF7 IC50
3 x 10-5μM
Compound: Epothilone B
Antiproliferative activity against human MCF7 cells assessed as cell growth inhibition
Antiproliferative activity against human MCF7 cells assessed as cell growth inhibition
[PMID: 37931226]
MCF7 IC50
38.17 nM
Compound: Epothilone B
Antiproliferative activity against human MCF7 cells after 2 days by MTT assay
Antiproliferative activity against human MCF7 cells after 2 days by MTT assay
[PMID: 30318441]
MCF7 IC50
7.4 × 10-5μM
Compound: Epothilone B
Cytotoxicity against human MCF7 cells measured after 5 days by MTT assay
Cytotoxicity against human MCF7 cells measured after 5 days by MTT assay
[PMID: 31021629]
MCF7 IC50
7.4 x 10-5μM
Compound: Epothilone B
Cytotoxicity against human MCF7 cells measured after 5 days by MTT assay
Cytotoxicity against human MCF7 cells measured after 5 days by MTT assay
[PMID: 31021629]
MCF7 IC50
8.1 × 10-5M
Compound: Epothilone B
Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
MCF7 IC50
8.1 x 10-5M
Compound: Epothilone B
Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
MCF7 IC50
81 μM
Compound: Epothilone B
Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
MHCC97H IC50
6.7 nM
Compound: Epothilone B
Antiproliferative activity against human MHCC97H after 72 hrs by CellTiter Glo assay
Antiproliferative activity against human MHCC97H after 72 hrs by CellTiter Glo assay
[PMID: 22320354]
MM1.S IC50
1 nM
Compound: 2; EPO B
Antiproliferative activity against human MM1S cells assessed as inhibition of cell proliferation
Antiproliferative activity against human MM1S cells assessed as inhibition of cell proliferation
[PMID: 30149324]
PC-3 GI50
1.7 nM
Compound: Epothilone B
Growth inhibition of human PC3 cells after 4 days by SRB assay
Growth inhibition of human PC3 cells after 4 days by SRB assay
[PMID: 28740601]
PC-3 IC50
0.28 × 10-5μM
Compound: Epothilone B
Antiproliferative activity against human PC-3 cells assessed as cell growth inhibition
Antiproliferative activity against human PC-3 cells assessed as cell growth inhibition
[PMID: 37931226]
PC-3 IC50
0.28 x 10-5μM
Compound: Epothilone B
Antiproliferative activity against human PC-3 cells assessed as cell growth inhibition
Antiproliferative activity against human PC-3 cells assessed as cell growth inhibition
[PMID: 37931226]
PC-3 IC50
1.6 nM
Compound: Epothilone B
Cytotoxicity against human PC3 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
Cytotoxicity against human PC3 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
[PMID: 31599583]
PC-3 IC50
1.6 × 10-3μM
Compound: Epothilone B
Cytotoxicity against human PC3 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
Cytotoxicity against human PC3 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
[PMID: 31599583]
PC-3 IC50
1.6 x 10-3μM
Compound: Epothilone B
Cytotoxicity against human PC3 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
Cytotoxicity against human PC3 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
[PMID: 31599583]
PC-3 IC50
2.2 nM
Compound: Epothilone B
Cytotoxicity against human PC3 cells measured after 5 days by MTT assay
Cytotoxicity against human PC3 cells measured after 5 days by MTT assay
[PMID: 31021629]
PC-3 IC50
2.2 × 10-3μM
Compound: Epothilone B
Cytotoxicity against human PC3 cells measured after 5 days by MTT assay
Cytotoxicity against human PC3 cells measured after 5 days by MTT assay
[PMID: 31021629]
PC-3 IC50
2.2 x 10-3μM
Compound: Epothilone B
Cytotoxicity against human PC3 cells measured after 5 days by MTT assay
Cytotoxicity against human PC3 cells measured after 5 days by MTT assay
[PMID: 31021629]
PC-3 IC50
2.5 × 10-4μM
Compound: Epothilone B
Cytotoxicity against human PC3 cells assessed as reduction in cell viability after 5 days by MTT assay
Cytotoxicity against human PC3 cells assessed as reduction in cell viability after 5 days by MTT assay
[PMID: 28398049]
PC-3 IC50
2.5 x 10-4μM
Compound: Epothilone B
Cytotoxicity against human PC3 cells assessed as reduction in cell viability after 5 days by MTT assay
Cytotoxicity against human PC3 cells assessed as reduction in cell viability after 5 days by MTT assay
[PMID: 28398049]
PC-3 IC50
7.1 × 10-5M
Compound: Epothilone B
Cytotoxicity against human PC-3 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against human PC-3 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
PC-3 IC50
7.1 x 10-5M
Compound: Epothilone B
Cytotoxicity against human PC-3 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against human PC-3 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
PC-3 IC50
71 μM
Compound: Epothilone B
Cytotoxicity against human PC-3 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against human PC-3 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
PLC-PRF-5 IC50
12.7 nM
Compound: Epothilone B
Antiproliferative activity against human PLC/PRF/5 after 72 hrs by CellTiter Glo assay
Antiproliferative activity against human PLC/PRF/5 after 72 hrs by CellTiter Glo assay
[PMID: 22320354]
PLC-PRF-5 IC50
3.8 nM
Compound: Epothilone B
Antiproliferative activity against human PLC/PRF/5 cells
Antiproliferative activity against human PLC/PRF/5 cells
[PMID: 22320354]
RPMI-8226 IC50
1 nM
Compound: 2; EPO B
Antiproliferative activity against human RPM18226 cells assessed as inhibition of cell proliferation
Antiproliferative activity against human RPM18226 cells assessed as inhibition of cell proliferation
[PMID: 30149324]
SK-OV-3 IC50
0.29 mM
Compound: Epothilone B
Cytotoxicity against human SK-OV-3 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against human SK-OV-3 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
SK-OV-3 IC50
1.8 × 10-4μM
Compound: Epothilone B
Antiproliferative activity against human SK-OV-3 cells assessed as cell growth inhibition
Antiproliferative activity against human SK-OV-3 cells assessed as cell growth inhibition
[PMID: 37931226]
SK-OV-3 IC50
1.8 x 10-4μM
Compound: Epothilone B
Antiproliferative activity against human SK-OV-3 cells assessed as cell growth inhibition
Antiproliferative activity against human SK-OV-3 cells assessed as cell growth inhibition
[PMID: 37931226]
SK-OV-3 IC50
2.36 × 10-5μM
Compound: Epothilone B
Cytotoxicity against human SKOV3 cells assessed as reduction in cell viability after 5 days by MTT assay
Cytotoxicity against human SKOV3 cells assessed as reduction in cell viability after 5 days by MTT assay
[PMID: 28398049]
SK-OV-3 IC50
2.36 x 10-5μM
Compound: Epothilone B
Cytotoxicity against human SKOV3 cells assessed as reduction in cell viability after 5 days by MTT assay
Cytotoxicity against human SKOV3 cells assessed as reduction in cell viability after 5 days by MTT assay
[PMID: 28398049]
SK-OV-3 IC50
2.4 × 10-4μM
Compound: Epothilone B
Cytotoxicity against human SKOV3 cells measured after 5 days by MTT assay
Cytotoxicity against human SKOV3 cells measured after 5 days by MTT assay
[PMID: 31021629]
SK-OV-3 IC50
2.4 x 10-4μM
Compound: Epothilone B
Cytotoxicity against human SKOV3 cells measured after 5 days by MTT assay
Cytotoxicity against human SKOV3 cells measured after 5 days by MTT assay
[PMID: 31021629]
SK-OV-3 IC50
2.8 × 10-4μM
Compound: Epothilone B
Cytotoxicity against human SKOV3 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
Cytotoxicity against human SKOV3 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
[PMID: 31599583]
SK-OV-3 IC50
2.8 x 10-4μM
Compound: Epothilone B
Cytotoxicity against human SKOV3 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
Cytotoxicity against human SKOV3 cells assessed as reduction in cell growth incubated for 5 days by MTT assay
[PMID: 31599583]
SK-OV-3 IC50
2.9 × 10-4M
Compound: Epothilone B
Cytotoxicity against human SK-OV-3 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against human SK-OV-3 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
SK-OV-3 IC50
2.9 x 10-4M
Compound: Epothilone B
Cytotoxicity against human SK-OV-3 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
Cytotoxicity against human SK-OV-3 cells assessed as inhibition of cell proliferation incubated for 5 days by MTT assay
[PMID: 35175766]
SMMC-7721 IC50
2.3 nM
Compound: Epothilone B
Antiproliferative activity against human SMMC7721 after 72 hrs by CellTiter Glo assay
Antiproliferative activity against human SMMC7721 after 72 hrs by CellTiter Glo assay
[PMID: 22320354]
SNU-182 IC50
22.3 nM
Compound: Epothilone B
Antiproliferative activity against human SNU182 after 72 hrs by CellTiter Glo assay
Antiproliferative activity against human SNU182 after 72 hrs by CellTiter Glo assay
[PMID: 22320354]
SNU-387 IC50
20 nM
Compound: Epothilone B
Antiproliferative activity against human SNU387 after 72 hrs by CellTiter Glo assay
Antiproliferative activity against human SNU387 after 72 hrs by CellTiter Glo assay
[PMID: 22320354]
SNU-398 IC50
2.9 nM
Compound: Epothilone B
Antiproliferative activity against human SNU398 after 72 hrs by CellTiter Glo assay
Antiproliferative activity against human SNU398 after 72 hrs by CellTiter Glo assay
[PMID: 22320354]
SNU-398 IC50
5 nM
Compound: Epothilone B
Antiproliferative activity against human SNU398 cells
Antiproliferative activity against human SNU398 cells
[PMID: 22320354]
SNU-423 IC50
10.3 nM
Compound: Epothilone B
Antiproliferative activity against human SNU423 after 72 hrs by CellTiter Glo assay
Antiproliferative activity against human SNU423 after 72 hrs by CellTiter Glo assay
[PMID: 22320354]
SNU-449 IC50
19.9 nM
Compound: Epothilone B
Antiproliferative activity against human SNU449 after 72 hrs by CellTiter Glo assay
Antiproliferative activity against human SNU449 after 72 hrs by CellTiter Glo assay
[PMID: 22320354]
SNU-475 IC50
11.6 nM
Compound: Epothilone B
Antiproliferative activity against human SNU475 after 72 hrs by CellTiter Glo assay
Antiproliferative activity against human SNU475 after 72 hrs by CellTiter Glo assay
[PMID: 22320354]
U-266 IC50
1 nM
Compound: 2; EPO B
Antiproliferative activity against human U266 cells assessed as inhibition of cell proliferation
Antiproliferative activity against human U266 cells assessed as inhibition of cell proliferation
[PMID: 30149324]
U2OS IC50
1.04 × 10-4μM
Compound: Epothilone B
Cytotoxicity against human U2OS cells assessed as reduction in cell viability after 5 days by MTT assay
Cytotoxicity against human U2OS cells assessed as reduction in cell viability after 5 days by MTT assay
[PMID: 28398049]
U2OS IC50
1.04 x 10-4μM
Compound: Epothilone B
Cytotoxicity against human U2OS cells assessed as reduction in cell viability after 5 days by MTT assay
Cytotoxicity against human U2OS cells assessed as reduction in cell viability after 5 days by MTT assay
[PMID: 28398049]
In Vitro

Epothilone B inhibits HCT116 cells with IC50 of 0.8 nM in HCT-116 cell line cytotoxicity assay[1]. Epothilone B (Patupilone) is a microtubule (MT) targeting agent. As shown by MTT cell proliferation assay, after 72 h of treatment Epothilone B efficiently inhibits cell growth with an IC50 of 6 nM, while concentrations ≤1 nM are not cytotoxic. Epothilone B significantly inhibits transwell cell migration at the non-cytotoxic concentration of 1 nM, and the effect is more evident at 10 nM[2]. Epothilone B (Patupilone) is a novel, non-taxane-related and nonneurotoxic microtubule-stabilizing agent in human medulloblastoma cell lines. Epothilone B reduces the proliferative activity in the D341 cell line, with an IC50 of 0.53 nM; in the D425Med cell line, with an IC50 of 0.37 nM; and in the DAOY cell line, with an IC50 of 0.19 nM. In the D341Med cell line, the effect of Epothilone B on clonogenic survival is at dose range of Epothilone B similar to the level of proliferative activity and viability (IC50, 0.50-0.75 nM). However, the clonogenicity of D425Med and DAOY cells is already strongly reduced at a 10-fold lower concentration of Epothilone B (IC50, 30 pM). These results overall demonstrate that Epothilone B is highly potent against different medulloblastoma cell lines[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Solvant et solubilité
In Vitro: 

DMSO : 100 mg/mL (196.97 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.9697 mL 9.8487 mL 19.6974 mL
5 mM 0.3939 mL 1.9697 mL 3.9395 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.08 mg/mL (4.10 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.08 mg/mL (4.10 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Pureté et documentation
Références

Vous serez peut-être également intéressé par les produits suivants :



Référence
Description
Cond.
Prix HT
HY-17595-1g
 1g 
HY-50759-5mg
 5mg